DE60238113D1 - Synthese und verfahren zu deren verwendung von tetrahydroindolon analogen und derivaten - Google Patents
Synthese und verfahren zu deren verwendung von tetrahydroindolon analogen und derivatenInfo
- Publication number
- DE60238113D1 DE60238113D1 DE60238113T DE60238113T DE60238113D1 DE 60238113 D1 DE60238113 D1 DE 60238113D1 DE 60238113 T DE60238113 T DE 60238113T DE 60238113 T DE60238113 T DE 60238113T DE 60238113 D1 DE60238113 D1 DE 60238113D1
- Authority
- DE
- Germany
- Prior art keywords
- derivatives
- tetrahydroindolon
- synthesis
- analog
- analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/839,289 US6759427B2 (en) | 2001-04-20 | 2001-04-20 | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
PCT/US2002/011142 WO2002085856A1 (en) | 2001-04-20 | 2002-04-08 | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60238113D1 true DE60238113D1 (de) | 2010-12-09 |
Family
ID=25279337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60238113T Expired - Lifetime DE60238113D1 (de) | 2001-04-20 | 2002-04-08 | Synthese und verfahren zu deren verwendung von tetrahydroindolon analogen und derivaten |
Country Status (7)
Country | Link |
---|---|
US (6) | US6759427B2 (de) |
EP (1) | EP1383742B1 (de) |
AT (1) | ATE486059T1 (de) |
DE (1) | DE60238113D1 (de) |
DK (1) | DK1383742T3 (de) |
ES (1) | ES2385932T3 (de) |
WO (1) | WO2002085856A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
JP4964593B2 (ja) * | 2003-09-25 | 2012-07-04 | セノメド バイオサイエンシーズ,エルエルシー | 神経学的病状の治療用のテトラヒドロインドロン誘導体 |
US20050107439A1 (en) * | 2003-11-10 | 2005-05-19 | Helton David R. | Composition and method for treating emesis |
WO2006133634A1 (fr) * | 2005-06-14 | 2006-12-21 | Beijing Gylongly Biodemtech Co., Ltd | Dérivés tétrahydroindole et dérivés tétrahydroindazole et leur utilisation |
WO2007101156A1 (en) * | 2006-02-27 | 2007-09-07 | Serenex, Inc. | Cyclohexylamino, benzene, pyridine, and pyridazine derivatives |
PL3851447T3 (pl) | 2006-10-12 | 2024-03-04 | Bellus Health Inc. | Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy |
EP2219648A4 (de) * | 2007-11-09 | 2010-11-03 | Cenomed Biosciences Llc | Behandlung von postraumatischem stress mit tetrahydroindolon-arylpiperazin-verbindungen |
US20090264443A1 (en) * | 2008-04-18 | 2009-10-22 | David Helton | Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds |
CN102448495A (zh) * | 2009-05-29 | 2012-05-09 | 安斯泰来制药株式会社 | 用于预防和/或治疗注意缺陷/多动障碍的新型医药组合物 |
RU2503452C2 (ru) * | 2011-11-24 | 2014-01-10 | Общество С Ограниченной Ответственностью "Консорциум-Пик" | Фармацевтическая композиция на основе растительной докозагексаеновой кислоты для профилактики синдрома гиперактивности у детей |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
WO2017184629A1 (en) | 2016-04-22 | 2017-10-26 | Becton, Dickinson And Company | Multiplex polymeric dye devices and methods for using the same |
CA3052595A1 (en) | 2017-02-08 | 2018-08-16 | Becton, Dickinson And Company | Dried dye reagent devices and methods for making and using the same |
US11992844B2 (en) | 2018-11-13 | 2024-05-28 | Becton, Dickinson And Company | Dried reagent strainers and methods for making and using the same |
AU2020417293A1 (en) | 2020-01-03 | 2022-09-01 | Berg Llc | Polycyclic amides as UBE2K modulators for treating cancer |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3300380A (en) | 1963-12-26 | 1967-01-24 | Upjohn Co | Diminishing toxicity of antiviral nu6-(hydroxyalkyl) adenines with 4-hydroxypyrazolo(3, 4-d) pyrimidine |
US3321369A (en) | 1965-05-26 | 1967-05-23 | Abbott Lab | Method of enhancing learning rate and retention level in warm blooded animals |
US3438968A (en) | 1966-06-23 | 1969-04-15 | Int Chem & Nuclear Corp | Substituted ammonium basic addition salts of ribonucleic acid |
BE759011A (fr) | 1969-11-17 | 1971-05-17 | Wellcome Found | Aminopurines |
DE2554453A1 (de) | 1974-12-18 | 1976-06-24 | Experimentales Et Cliniques De | Medikament zur glykaemieregulierung |
GB1530912A (en) | 1975-02-13 | 1978-11-01 | Wellcome Found | Compositions containing 9-(2-hydroxy-3-alkyl)-adenines |
US4138562A (en) | 1977-02-09 | 1979-02-06 | The Regents Of The University Of Minnesota | Adenosine deaminase resistant antiviral purine nucleosides and method of preparation |
US4221910A (en) | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
US4221909A (en) | 1978-09-15 | 1980-09-09 | Sloan-Kettering Institute For Cancer Research | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
US4221794A (en) | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
US4340726A (en) | 1980-03-14 | 1982-07-20 | Newport Pharmaceuticals International, Inc. | Esters |
US4347360A (en) | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
US4451478A (en) | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
US4977178A (en) * | 1982-09-20 | 1990-12-11 | Pfizer Inc. | Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
US5093318A (en) | 1983-11-01 | 1992-03-03 | Scripps Clinic And Research Foundation | Immunostimulating guanosine derivatives and their pharmaceutical compositions |
US4952693A (en) | 1984-10-12 | 1990-08-28 | Warner-Lambert Company | Oxazolo-pyrimidine derivatives |
JPH0696534B2 (ja) | 1986-04-25 | 1994-11-30 | ヘキストジヤパン株式会社 | 抗痴呆剤 |
US5495010A (en) | 1987-04-17 | 1996-02-27 | The United States Of America As Represented By The Department Of Health And Human Services | Acid stable purine dideoxynucleosides |
EP0691348A1 (de) | 1988-04-19 | 1996-01-10 | Institut Pasteur | Aus Adenylat-Cyclase von B. Parapertussis hergestellte immunogemische Zusammensetzungen |
US5256677A (en) | 1989-05-23 | 1993-10-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5187162A (en) | 1989-09-15 | 1993-02-16 | Gensia Pharmaceuticals | Methods of treating neurodegenerative conditions |
US5026687A (en) | 1990-01-03 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds |
US5091432A (en) | 1990-03-28 | 1992-02-25 | Glasky Alvin J | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
US5237051A (en) | 1990-12-06 | 1993-08-17 | Vanderbilt University | Purified enterotoxin receptor protein |
US5319096A (en) | 1992-04-03 | 1994-06-07 | Hoechst-Roussel Pharmaceuticals Inc. | (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use |
US5447939A (en) | 1994-07-25 | 1995-09-05 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US5801184A (en) | 1994-07-25 | 1998-09-01 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US5644568A (en) * | 1995-03-15 | 1997-07-01 | Motorola, Inc. | Method and apparatus for organizing and recovering information communicated in a radio communication system |
FR2736640B1 (fr) * | 1995-07-13 | 1997-08-22 | Oreal | Compositions de teinture des fibres keratiniques contenant des derives n-substitues du 4-hydroxy indole, nouveaux derives, leur procede de synthese, leur utilisation pour la teinture, et procede de teinture |
JP2842816B2 (ja) * | 1995-10-16 | 1999-01-06 | 日本電気アイシーマイコンシステム株式会社 | 半導体記憶装置 |
US5795756A (en) | 1995-12-11 | 1998-08-18 | Johnson; Roger A. | Method and compounds for the inhibition of adenylyl cyclase |
US5948771A (en) | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
US5801159A (en) | 1996-02-23 | 1998-09-01 | Galileo Laboratories, Inc. | Method and composition for inhibiting cellular irreversible changes due to stress |
US6303617B1 (en) | 1998-05-04 | 2001-10-16 | Neotherapeutics, Inc. | Serotonin-like 9-substituted hypoxanthine and methods of use |
AU3785799A (en) | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Method for treating migraine in mammals |
AU3879899A (en) | 1998-05-04 | 1999-11-23 | Neotherapeutics, Inc. | Novel dopamine-like 9-substituted hypoxanthine and methods of use |
GB9812038D0 (en) | 1998-06-04 | 1998-07-29 | Merck Sharp & Dohme | Therapeutic compound |
US6534651B2 (en) * | 2000-04-06 | 2003-03-18 | Inotek Pharmaceuticals Corp. | 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof |
US20020040031A1 (en) * | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for prevention of accumulation of amyloid beta peptide in the central nervous system |
US20020040032A1 (en) * | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for stimulation of synthesis of synaptophysin in the central nervous system |
US20020128264A1 (en) * | 2000-07-07 | 2002-09-12 | Taylor Eve M. | Methods for treatment of conditions affected by activity of multidrug transporters |
DK1790344T3 (da) * | 2000-07-07 | 2011-05-02 | Spectrum Pharmaceuticals Inc | Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande |
US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
US6770638B2 (en) * | 2001-04-20 | 2004-08-03 | Spectrum Pharmaceuticals, Inc. | Tetrahydroindolone and purine derivatives linked to arylpiperazines |
JP4964593B2 (ja) * | 2003-09-25 | 2012-07-04 | セノメド バイオサイエンシーズ,エルエルシー | 神経学的病状の治療用のテトラヒドロインドロン誘導体 |
-
2001
- 2001-04-20 US US09/839,289 patent/US6759427B2/en not_active Expired - Lifetime
-
2002
- 2002-04-08 EP EP02725584A patent/EP1383742B1/de not_active Expired - Lifetime
- 2002-04-08 ES ES02725584T patent/ES2385932T3/es not_active Expired - Lifetime
- 2002-04-08 WO PCT/US2002/011142 patent/WO2002085856A1/en not_active Application Discontinuation
- 2002-04-08 DK DK02725584.3T patent/DK1383742T3/da active
- 2002-04-08 AT AT02725584T patent/ATE486059T1/de active
- 2002-04-08 DE DE60238113T patent/DE60238113D1/de not_active Expired - Lifetime
- 2002-07-09 US US10/193,550 patent/US6982269B2/en not_active Expired - Fee Related
-
2004
- 2004-12-01 US US11/002,329 patent/US7531670B2/en not_active Expired - Fee Related
-
2009
- 2009-03-30 US US12/414,539 patent/US8063233B2/en not_active Expired - Lifetime
-
2011
- 2011-09-27 US US13/246,014 patent/US8377456B2/en not_active Expired - Lifetime
-
2013
- 2013-02-19 US US13/770,937 patent/US8734818B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002085856A1 (en) | 2002-10-31 |
US8063233B2 (en) | 2011-11-22 |
US7531670B2 (en) | 2009-05-12 |
US20130225648A1 (en) | 2013-08-29 |
US8734818B2 (en) | 2014-05-27 |
ATE486059T1 (de) | 2010-11-15 |
EP1383742B1 (de) | 2010-10-27 |
US6759427B2 (en) | 2004-07-06 |
US8377456B2 (en) | 2013-02-19 |
US20090192319A1 (en) | 2009-07-30 |
US20030022892A1 (en) | 2003-01-30 |
US6982269B2 (en) | 2006-01-03 |
US20050096317A1 (en) | 2005-05-05 |
US20020198218A1 (en) | 2002-12-26 |
EP1383742A1 (de) | 2004-01-28 |
ES2385932T3 (es) | 2012-08-03 |
US20120070385A1 (en) | 2012-03-22 |
DK1383742T3 (da) | 2011-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60238113D1 (de) | Synthese und verfahren zu deren verwendung von tetrahydroindolon analogen und derivaten | |
DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
DE602004017736D1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
ATE269295T1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
DE60301350D1 (de) | Verfahren zur herstellung von 7-substituierten -3-chinolin und 3-chinol-4-on carbonitrile | |
DE60027913D1 (de) | 5-beta-sapogenin und pseudosapogeninderivate und ihre verwendung zur behandlung von demenz | |
DE60204548D1 (de) | Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit | |
BRPI0413022A (pt) | derivados de 3-amino cromado e 2-amino tetralina | |
DE60142410D1 (de) | Immunomodulatorische polynukleotide und verfahren zur deren verwendung | |
DE10291574D2 (de) | Vorrichtung und Verfahren zum katalytischen Reformieren von Kohlenwasserstoffen oder Alkoholen | |
DE60001387D1 (de) | Verfahren und katalysator zur zersetzung von distickstoffmonoxid | |
ATE288911T1 (de) | Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten | |
DE10107712B4 (de) | Vorrichtung und Verfahren zur energetischen Nutzung von Faulschlammvergasungsgas | |
ATE388135T1 (de) | Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen | |
DE60304109D1 (de) | Verfahren zur Herstellung von Ringelementen und Vorrichtung zu dessen Durchführung | |
ATE215373T1 (de) | 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss | |
DE59712772D1 (de) | Verfahren zur fraktionierten Kristallisation von Substanzen, zur Durchführung des Verfahrens geeigneter Kristallisator, sowie Verwendung des Kristallisators | |
DE60043207D1 (de) | Verfahren und Vorrichtung zur Reinigung von Gasen | |
DE60021960D1 (de) | Verfahren zur Kompensation von Neigung und/oder Defokussierung, und Vorrichtung für dasselbige | |
DE69823372T8 (de) | Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen | |
DE60307830D1 (de) | Neue multimerische moleküle, verfahren zu deren herstellung, und deren verwendung zur herstellung von arzneimitteln | |
ATE423110T1 (de) | Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen | |
DE50111926D1 (de) | Strahlungsanordnung sowie deren Verwendung und Verfahren zur Behandlung von Oberflächen | |
ATE522205T1 (de) | Testosteronhaltiges transdermales therapeutisches system und verfahren zu seiner herstellung | |
DE60232696D1 (de) | Verfahren und Vorrichtung zur Behandlung von Synthesegas und verwandten Gasen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 20099 HAMBURG |